Having spent two months as the head of Novartis South Africa, what is your first assignment as General Manager, could you share with our readers what…
In Conversation
Mr. Miller, you have been Vice President and Managing Director of Mylan’s operations in South Africa since 2008. What mission were you assigned back then, and…
South Africa carries one of the world’s most disproportionate disease burdens, the worst of so-called westernised diseases, such as cardiac disease, diabetes etc on the one…
Mr Norman, could you tell us a few words on the transformation process that the company is currently going through? Takeda acquired Nycomed in October 2011,…
If we take a look at MSD’s international presence, the group has grown into the third largest pharma company in the world. Here in South Africa,…
Focus Reports is back in South Africa as part of a second set of reports on the BRICS. What would you say are the main changes…
Ms Joubert, could you start by telling our readers over the 16 months of heading the operations here, what have been the most challenging situations as…
The line between research based pharmaceutical companies and generic companies is today less and less relevant, as we have seen in the past few years generic…
Mr. Godard, you previously worked in Europe for Baxter Edwards Life Sciences, what made you decide to move to South Africa in a smaller company? It…
Your professional career went back and forth between creating your own business and running a smaller and very dynamic structure and managing over a thousand of…
You were recently appointed at the head of Eli Lilly South African operations. What is the specific mission you have been given? Eli Lilly South Africa…
Since we interviewed you in 2005, there have been many changes in the market, from consolidation, an increasing generic penetration, to new healthcare reforms… How have…
